CIK: 0001844645 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 13, 2025
Total Value ($000): $161,343 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OCS | OCULIS HOLDING AG | 2,300,774 | $44,658 | 27.7% | $12.64 | +45.4% | ORDINARY SHARES | H5870P102 |
| PCVX | VAXCYTE INC | 1,305,125 | $42,430 | 26.3% | $38.90 | -15.7% | COM | 92243G108 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 2,120,508 | $29,730 | 18.4% | $11.27 | +24.4% | COM | 03969K108 |
| — | INOZYME PHARMA INC | 4,494,851 | $17,979 | 11.1% | $10.48 | — | COM | 45790W108 |
| ZBIO | ZENAS BIOPHARMA INC | 779,045 | $7,549 | 4.7% | $17.27 | -43.6% | COM | 98937L105 |
| TRVI | TREVI THERAPEUTICS INC | 1,146,110 | $6,269 | 3.9% | $6.22 | 0.0% | COM | 89532M101 |
| — | VIGIL NEUROSCIENCE INC | 560,595 | $4,457 | 2.8% | $7.03 | — | COM | 92673K108 |
| RXRX | RECURSION PHARMACEUTICALS IN | 595,518 | $3,013 | 1.9% | $6.72 | -26.9% | CL A | 75629V104 |
| BIOA | BIOAGE LABS INC | 653,374 | $2,698 | 1.7% | $19.50 | -79.3% | COM | 09077V100 |
| IOBT | IO BIOTECH INC | 864,197 | $1,201 | 0.7% | $1.76 | -34.9% | COM | 449778109 |
| — | RALLYBIO CORP | 2,404,644 | $813 | 0.5% | $16.97 | — | COM | 75120L100 |
| BOLT | BOLT BIOTHERAPEUTICS INC | 94,573 | $546 | 0.3% | $6.62 | 0.0% | COM NEW | 097702203 |